UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial

The Lancet (British edition), 2017-07, Vol.390 (10093), p.480-489

2017

Volltextzugriff (PDF)

Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study

Neuropsychopharmacology (New York, N.Y.), 2017-03, Vol.42 (4), p.844-853

2017

Volltextzugriff (PDF)

Liraglutide effects in a paediatric (7‐11 y) population with obesity: A randomized, double‐blind, placebo‐controlled, short‐term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics

Pediatric obesity, 2019-05, Vol.14 (5), p.e12495-n/a

2019

Volltextzugriff (PDF)

2.45 A Phase 4, Open-Label, Multicenter, Single-Dose Study of the Pharmacokinetics of a Novel Amphetamine Extended-Release Oral Disintegrating Tablet Formulation (Adzenys XR-ODT™) in Preschool-Aged Children

Journal of the American Academy of Child and Adolescent Psychiatry, 2018-10, Vol.57 (10), p.S173-S174

2018

Volltextzugriff (PDF)

PF-06649751 efficacy and safety in early Parkinson’s disease: a randomized, placebo-controlled trial

Therapeutic advances in neurological disorders, 2020, Vol.13, p.1756286420911296-1756286420911296

2020

Volltextzugriff (PDF)

Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine

British journal of psychiatry, 2011-01, Vol.198 (1), p.51-58

2011

Volltextzugriff (PDF)

Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens

Journal of clinical pharmacology, 2015-09, Vol.55 (9), p.985-994

2015

Volltextzugriff (PDF)

Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine

Bipolar disorders, 2012-02, Vol.14 (1), p.31-40

2012

Volltextzugriff (PDF)

Self-Reported Sedation Profile of Quetiapine Extended-Release and Quetiapine Immediate-Release During 6-Day Initial Dose Escalation in Bipolar Depression: A Multicenter, Randomized, Double-Blind, Phase IV Study

Clinical therapeutics, 2012-11, Vol.34 (11), p.2202-2211

2012

Volltextzugriff (PDF)

Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine-naloxone in subjects receiving stable addiction management therapy

Antimicrobial agents and chemotherapy, 2015-01, Vol.59 (1), p.498-504

2015

Volltextzugriff (PDF)

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials

The Lancet (British edition), 2018-09, Vol.392 (10152), p.1058-1070

2018

Volltextzugriff (PDF)

Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age

The New England journal of medicine, 2022-01, Vol.386 (1), p.35-46

2022

Volltextzugriff (PDF)

Trial of SAGE-217 in Patients with Major Depressive Disorder

The New England journal of medicine, 2019-09, Vol.381 (10), p.903-911

2019

Volltextzugriff (PDF)

Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study

Neurology, 2018-12, Vol.91 (24), p.e2222

2018

Volltextzugriff (PDF)

Brexanolone in Adolescent Patients with Postpartum Depression: Results from the Phase 3, Open-Label CHICKADEE Study

American journal of obstetrics and gynecology, 2022-01, Vol.226 (1), p.S79-S79

2022

Volltextzugriff (PDF)

Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study

The journal of clinical psychiatry, 2023-08, Vol.84 (5)

2023

Volltextzugriff (PDF)

Effect of Raltegravir on the Pharmacokinetics of Methadone

Journal of clinical pharmacology, 2010-12, Vol.50 (12), p.1461-1466

2010

Volltextzugriff (PDF)

Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program

Journal of affective disorders, 2023-01, Vol.320, p.353-359

2023

Volltextzugriff (PDF)

7.10 PHARMACOKINETICS AND SAFETY/TOLERABILITY PROFILE OF CARIPRAZINE IN PEDIATRIC PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER

Journal of the American Academy of Child and Adolescent Psychiatry, 2020-10, Vol.59 (10), p.S171-S171

2020

Volltextzugriff (PDF)

3.39 Safety, Tolerability, and Pharmacokinetics of Cariprazine in Pediatric Patients With ASD

Journal of the American Academy of Child and Adolescent Psychiatry, 2022-10, Vol.61 (10), p.S240-S240

2022

Volltextzugriff (PDF)

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet infectious diseases, 2022-12, Vol.22 (12), p.1703-1715

2022

Volltextzugriff (PDF)

Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age

The New England journal of medicine, 2023-02, Vol.388 (7), p.621-634

2023

Volltextzugriff (PDF)

Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study

Brain (London, England : 1878), 2023-06, Vol.146 (6), p.2275-2284

2023

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(86)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(50)
Humans
(39)
Female
(32)
Male
(31)
Adult
(26)
Double-Blind Method
(21)
Middle Aged
(21)
Psychiatry
(17)
Treatment Outcome
(17)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Neurosciences & Neurology
(14)
Pharmacology & Pharmacy
(14)
Psychiatric Status Rating Scales
(12)
Adolescent
(11)
Clinical Neurology
(10)
Clinical Trials
(10)
Pharmacology. Drug Treatments
(10)
Psychology. Psychoanalysis. Psychiatry
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial

Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study

Liraglutide effects in a paediatric (7‐11 y) population with obesity: A randomized, double‐blind, placebo‐controlled, short‐term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics

2.45 A Phase 4, Open-Label, Multicenter, Single-Dose Study of the Pharmacokinetics of a Novel Amphetamine Extended-Release Oral Disintegrating Tablet Formulation (Adzenys XR-ODT™) in Preschool-Aged Children

PF-06649751 efficacy and safety in early Parkinson’s disease: a randomized, placebo-controlled trial

Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine

Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens

Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine

Self-Reported Sedation Profile of Quetiapine Extended-Release and Quetiapine Immediate-Release During 6-Day Initial Dose Escalation in Bipolar Depression: A Multicenter, Randomized, Double-Blind, Phase IV Study

Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine-naloxone in subjects receiving stable addiction management therapy

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials

Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age

Trial of SAGE-217 in Patients with Major Depressive Disorder

Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study

Brexanolone in Adolescent Patients with Postpartum Depression: Results from the Phase 3, Open-Label CHICKADEE Study

Cariprazine for the Adjunctive Treatment of Major Depressive Disorder in Patients With Inadequate Response to Antidepressant Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Effect of Raltegravir on the Pharmacokinetics of Methadone

Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program

7.10 PHARMACOKINETICS AND SAFETY/TOLERABILITY PROFILE OF CARIPRAZINE IN PEDIATRIC PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER

3.39 Safety, Tolerability, and Pharmacokinetics of Cariprazine in Pediatric Patients With ASD

Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age

Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study

Suchergebnisse filtern